Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy

American Journal of Gastroenterology

Volumn 92, Issue 3, 1997, Pages 429-437

  Sontag, Stephen J ^a   Kogut, David G ^b   Fleischmann, Roy ^b   Campbell, Donald R ^b   Richter, Joel ^b   Robinson, Malcolm ^b   McFarland, Miles ^b   Sabesin, Seymour ^b   Lehman, Glen A ^b   Castell, Donald ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; ATTAPULGITE; GASTRIN; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; RANITIDINE;

ARTICLE; ASTHENIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SCREENING; ESOPHAGOSCOPY; GASTRIN BLOOD LEVEL; HEADACHE; HEARTBURN; HUMAN; ISCHEMIA; MAJOR CLINICAL STUDY; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RASH; REFLUX ESOPHAGITIS; VERTIGO;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AGED; ANTACIDS; ANTI-ULCER AGENTS; DOUBLE-BLIND METHOD; DRUG RESISTANCE; ESOPHAGITIS, PEPTIC; ESOPHAGOSCOPY; FASTING; FEMALE; FOLLOW-UP STUDIES; GASTRINS; HEARTBURN; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; RANITIDINE; SAFETY; SLEEP; SLEEP STAGES; ULCER; WOUND HEALING;

EID: 19244380749     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Nebel OT, Forbes MF, Castell DO. Symptomatic gastroesophageal reflux: Incidence and precipitating factors. Am J Dig Dis 1976;21: 953-6.
2. Norrelund N, Pedersen PA. Prevalence of gastro-oesophageal reflux-like dyspepsia. International Congress of Gastroenterology, Rome, September 1988:4-10. A1031 (abstract).
3. The Gallup Organization. Gallup survey on heartburn across America. Princeton, NJ: The Gallup Organization, March 24, 1988.
4. Schnell T, Sontag S, Wanner J, et al. Endoscopic screening for Barrett's esophagus, esophageal adenocarcinoma and other mucosal changes in ambulatory subjects with symptomatic gastroesophageal reflux. Gastroenterology 1985;88:1576 (abstract).
5. Behar J, Biancani P, Sheahan DG. Evaluation of esophageal tests in the diagnosis of reflux esophagitis. Gastroenterology 1976;71:9-15.
6. Johansson KE, Ask P, Boeryd B, et al. Oesophagitis, signs of reflux, and gastric acid secretion in patients with symptoms of gastro-oesophageal reflux disease. Scand J Gastroenterol 1986;21:837-47.
7. Goldberg HI, Dodds WJ, Gee S, et al. Role of acid and pepsin in acute experimental esophagitis. Gastroenterology 1969;56:223-30.
8. Hendrix TR, Yardley JH. Consequences of gastroesophageal reflux. Clin Gastroenterol 1976;5:155-74.
9. Demeester TR, Jonson LF, Joseph GJ, et al. Patterns of gastroesophageal reflux in health and disease. Ann Surg 1976;184:459-69.
10. Janssens J, Vantrappen G, Peelers TL, Ghillebert G. How do 24-hour pH measurements distinguish the disease spectrum of reflux patients. Gastroenterology 1985;88:A1431 (abstract).
11. Sontag SJ. Rolling review: Gastro-oesophageal reflux disease. Aliment Pharmacol Ther 1993;7:293-312.
12. Johnson NJ, Boyd EJS, Mills JG, et al. Acute treatment of reflux esophagitis: A multicenter trial to compare 150 mg ranitidine b.d. with 300 mg ranitidine q.d.s. Aliment Pharmacol Ther 1989;3:259-66.
13. Sharma BK, Walt RP, Pounder RE, et al. Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity. Gut 1984;25:957-64.
14. Naesdal J, Bodemar G, Walan A. Effect of omeprazole, a substituted benzimidazole, on 24-hour intragastric acidity in patients with peptic ulcer disease. Scand J Gastroenterol 1984;19:916-22.
15. Walt RP, Gomes M de FA, Wood EC, et al. Effect of daily oral omeprazole on 24-hour intragastric acidity. Br Med J 1983;287:12-4.
16. Dent J, Klinkenberg-Knol EC, Elm G, et al. Omeprazole in the long-term management of patients with reflux Oesophagitis refractory to histamine H (2)-receptor antagonists. Scand J Gastroenterol 1989; 24(suppl 166):A176 (abstract).
17. Bardhan KD, Morris P, Thompson M, et al. Omeprazole in the treatment of erosive oesophagitis refractory to high dose cimetidine and ranitidine. Gut 1990;31:745-9.
18. 2-receptor antagonists. Scand J Gastroenterol 1989;166:88-93.
19. 2-receptor antagonists. Aliment Pharmacol Ther 1990;4:145-55.
20. 2-blockers. Gastroenterology 1988;94:A436 (abstract).
21. 2 RA-resistant erosive reflux esophagitis. Gastroenterology 1990;98: A113 (abstract).
22. 2-receptor antagonist therapy. Am J Gastroenterol 1993;88:1212-7.
23. Tartov AR, Ware JE, Greenfield S, et al. The medical outcomes study: An application of methods for monitoring the results of medical care. JAMA 1989;262:925-30.
24. Campbell DT, Fiske DW. Convergent and discriminant validation by the multitrait-multimethod matrix. Psychol Bull 1959;56:81-105.
25. Solcia E, Capella C, Vassallo G, et al. Endocrine cells of the gastric mucosa. Int Rev Cytol 1975;42:223-86.
26. Solcia E, Bordi C, Creutzfeldt W, et al. Histopathological classification of nonantral gastric endocrine growths in man. Digestion 1988;41: 185-200.
27. Benhaim MC, Evreux M, Salducci J, et al. Lansoprazole and ranitidine in treatment of reflux oesophagitis: double blind comparative trial. Gastroenterology 1990;98:A20 (abstract).
28. Bardhan KD, Long R, Hawkey CJ, et al. Lansoprazole, a new proton-pump inhibitor, vs ranitidine in the treatment of reflux erosive esophagitis. Gastroenterology 1991;100:A30 (abstract).
29. Robinson M, Kogut D, Jennings D, et al. Lansoprazole heals erosive reflux esophagitis better than ranitidine. Gastroenterology 1992;102: A153 (abstract).
30. Dorsch E, Jones J, Padgett C, et al. Lansoprazole heals moderate to severe reflux esophagitis. Am J Gastroenterol 1991;86:A1294 (abstract).
31. Sontag S, Schnell T, Kurucar C, et al. Lansoprazole heals erosive reflux esophagitis in patients with Barrett's esophagus. Am J Gastroenterol 1993;88:A74 (abstract).
32. Hatlebakk JG, Berstad A, Carling L, et al. Lansoprazole versus omeprazole in short-term treatment of reflux oesophagitis: Results of a Scandinavian multicentre trial. Scand J Gastroenterol 1993;28:224-8.
33. Sontag S, Schnell T, Miller T, et al. The importance of hiatal hernia in reflux esophagitis compared with lower esophageal sphincter pressure or smoking. J Clin Gastroenterol 1991;13:628-43.
34. Mittal RK, Rochester DF, McCallum RW. Effect of the diaphragmatic contraction on lower oesophageal sphincter pressure in man. Gut 1987;28:1564-8.
35. Mittal RK, Rochester DF, McCallum RW. Sphincteric action of the diaphragm during a relaxed lower esophageal sphincter. Am J Physiol 1989;256:G139-44.
36. Mittal RK, Fisher M. Electrical and mechanical inhibition of the crural diaphragm during transient relaxation of the lower esophageal sphincter. Gastroenterology 1990;99:1265-8.
37. Sloan S, Rademaker AW, Kahrilas PJ. Determinants of gastroesophageal junction incompetence: Hiatal hernia, lower esophageal sphincter, or both? Ann Intern Med 1992;117:977-82.